リアルタイムPCR市場：製品、用途、エンドユーザー別-2025-2030年世界予測

リアルタイムPCR市場は、2023年に34億4,000万米ドルと評価され、2024年には37億6,000万米ドルに達すると予測され、CAGR 9.74%で成長し、2030年には66億米ドルになると予測されています。

定量PCR（qPCR）としても知られるリアルタイムPCRは、標的DNA分子の増幅と同時定量に使用される強力な分子生物学的手法です。この方法は、遺伝子発現解析、病原体検出、遺伝子変異解析などのアプリケーションや、臨床診断、バイオテクノロジー、法医学、研究室などの分野における核酸配列の測定において、その精度が極めて重要です。リアルタイムPCRは、COVID-19のような流行の問題を含む感染症の診断にますます不可欠となっている、迅速、正確、効率的な結果を提供する能力によって人気を集めています。この市場は、ゲノム研究の進歩、持続可能な農業への需要の高まり、個別化医療の動向により拡大しており、正確な遺伝子評価の必要性を煽っています。主な成長要因としては、精度と感度を向上させる技術革新、研究開発に対する政府資金の増加、疾患の早期発見に対する意識の高まりなどが挙げられます。しかし、装置コストの高さ、熟練者の必要性、異なるプラットフォーム間での標準化の限界といった課題は、成長の妨げになる可能性があります。自動化を強化し、より費用対効果の高い装置を開発し、検査室のインフラが整備されつつある未開拓の地域に進出することで、チャンスは広がります。技術革新の可能性は、qPCRとデジタル技術の統合、クラウドベースのデータ解析の促進、フィールドアプリケーション用のポータブルPCR装置の進歩にあります。成長機会を活用するため、企業は多重化技術とポータブル機器のイノベーションへの研究開発投資に注力すべきです。市場競争は、技術の進歩と診断需要への対応競争に大きく左右され、ダイナミックで将来性のある軌道を示しています。明らかになった限界を克服するために戦略を調整し、新たな動向をターゲットにすることで、持続的な成長と市場でのリーダーシップを促進することができます。

市場力学：急速に進化するリアルタイムPCR市場の主要市場インサイトを公開

リアルタイムPCR市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 感染症および遺伝性疾患の流行
  • 疾病診断のためのバイオマーカープロファイリングの急速な利用
  • 病気の原因となる微生物の早期診断と臨床診断検査の利用の増加
• 市場抑制要因
  • リアルタイムPCRに関連する高い装置コスト
• 市場機会
  • コンパクト、ポータブル、ラボオンチップPCR装置の継続的な技術統合と開発
  • 植物由来からゲノムベースの創薬への急速なシフト
• 市場の課題
  • リアルタイムPCR技術の技術的限界と熟練専門家の不足

ポーターの5つの力：リアルタイムPCR市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、リアルタイムPCR市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：リアルタイムPCR市場における外部からの影響の把握

外部マクロ環境要因は、リアルタイムPCR市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析リアルタイムPCR市場における競合情勢の把握

リアルタイムPCR市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的な意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスリアルタイムPCR市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、リアルタイムPCR市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨リアルタイムPCR市場における成功への道筋を描く

リアルタイムPCR市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 感染症および遺伝性疾患の蔓延
    • 疾患診断のためのバイオマーカープロファイリングの迅速な利用
    • 病原微生物の早期診断と臨床診断検査の利用の増加
  • 抑制要因
    • リアルタイムPCRに関連するデバイスコストが高い
  • 機会
    • コンパクトでポータブルなラボオンチップPCRデバイスの継続的な技術統合と開発
    • 植物由来からゲノムベースの創薬への急速な移行
  • 課題
    • リアルタイムPCR技術の技術的限界と熟練した専門家の不足
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 リアルタイムPCR市場：製品別

• 機器
• 試薬・消耗品
• ソフトウェアとサービス

第7章 リアルタイムPCR市場：用途別

• 臨床
• 法医学
• 調査

第8章 リアルタイムPCR市場：エンドユーザー別

• 臨床調査機関
• 法医学研究所
• 病院と診断センター
• 製薬・バイオテクノロジー企業
• 調査室および学術機関

第9章 南北アメリカのリアルタイムPCR市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のリアルタイムPCR市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのリアルタイムPCR市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Agilent Technologies, Inc.
• Analytik Jena GmbH
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• bioMerieux Sweden AB
• Bioneer Corporation
• Danaher Corporation
• ELITechGroup
• Enzo Life Sciences, Inc.
• F. Hoffmann-La Roche Ltd.
• Merck KGaA
• Promega Corporation
• QIAGEN GmbH
• Takara Bio Inc.
• Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. REAL-TIME PCR MARKET RESEARCH PROCESS
• FIGURE 2. REAL-TIME PCR MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL REAL-TIME PCR MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL REAL-TIME PCR MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL REAL-TIME PCR MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL REAL-TIME PCR MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES REAL-TIME PCR MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES REAL-TIME PCR MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. REAL-TIME PCR MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. REAL-TIME PCR MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. REAL-TIME PCR MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL REAL-TIME PCR MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL REAL-TIME PCR MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. REAL-TIME PCR MARKET DYNAMICS
• TABLE 7. GLOBAL REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL REAL-TIME PCR MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL REAL-TIME PCR MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL REAL-TIME PCR MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL REAL-TIME PCR MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL REAL-TIME PCR MARKET SIZE, BY FORENSICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL REAL-TIME PCR MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL REAL-TIME PCR MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL REAL-TIME PCR MARKET SIZE, BY FORENSIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL REAL-TIME PCR MARKET SIZE, BY HOSPITALS & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL REAL-TIME PCR MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL REAL-TIME PCR MARKET SIZE, BY RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 31. CANADA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. CANADA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. CANADA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES REAL-TIME PCR MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. AUSTRALIA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 48. CHINA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. CHINA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. CHINA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 51. INDIA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. INDIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. INDIA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. INDONESIA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. JAPAN REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. MALAYSIA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. PHILIPPINES REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. SINGAPORE REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. SOUTH KOREA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. TAIWAN REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. THAILAND REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. VIETNAM REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 84. EUROPE, MIDDLE EAST & AFRICA REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. DENMARK REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. EGYPT REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. FINLAND REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. FRANCE REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. GERMANY REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. ISRAEL REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 103. ITALY REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 104. ITALY REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. ITALY REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. NETHERLANDS REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. NIGERIA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. NORWAY REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 115. POLAND REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. POLAND REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. POLAND REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 118. QATAR REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119. QATAR REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. QATAR REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. RUSSIA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. SAUDI ARABIA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. SOUTH AFRICA REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. SPAIN REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. SWEDEN REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. SWITZERLAND REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. TURKEY REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. UNITED ARAB EMIRATES REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM REAL-TIME PCR MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM REAL-TIME PCR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. UNITED KINGDOM REAL-TIME PCR MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 148. REAL-TIME PCR MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 149. REAL-TIME PCR MARKET, FPNV POSITIONING MATRIX, 2023

The Real-time PCR Market was valued at USD 3.44 billion in 2023, expected to reach USD 3.76 billion in 2024, and is projected to grow at a CAGR of 9.74%, to USD 6.60 billion by 2030.

Real-time PCR, also known as quantitative PCR (qPCR), is a powerful molecular biology technique used for the amplification and simultaneous quantification of a targeted DNA molecule. This method is crucial for its precision in measuring nucleic acid sequences, fundamental in applications like gene expression analysis, pathogen detection, genetic variation analysis, and in areas such as clinical diagnostics, biotechnology, forensic science, and research laboratories. Real-time PCR is gaining traction due to its ability to deliver rapid, accurate, and efficient results, which is increasingly critical for diagnosing infectious diseases, including prevalent issues such as COVID-19. The market is expanding due to advancements in genomic research, a growing demand for sustainable agriculture practices, and personalized medicine trends, fueling the need for precise genetic assessments. Key growth factors include technological innovations improving accuracy and sensitivity, increased governmental funding for R&D, and rising awareness of early disease detection. However, challenges such as the high cost of equipment, the need for skilled personnel, and limitations in standardization across different platforms might hinder growth. Opportunities thrive in enhancing automation, developing more cost-effective devices, and expanding into untapped regions where laboratory infrastructure is developing. Potential innovations lie in integrating qPCR with digital technologies, promoting cloud-based data analytics, and advancing portable PCR devices for field applications. To capitalize on growth opportunities, firms should focus on R&D investments in multiplexing techniques and portable device innovations. The market is competitive, driven heavily by technological advancements and the race to meet diagnostic demands, indicating a dynamic and future-forward trajectory. Adjusting strategies to overcome identified limitations and targeting emerging trends can facilitate sustained growth and market leadership.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Real-time PCR Market

The Real-time PCR Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Prevalence of infectious diseases and genetic disorders
  • Rapid utilization of biomarker profiling for disease diagnostics
  • Rising early diagnosis of disease-causing microbes and the use of clinical diagnostic tests
• Market Restraints
  • High device costs associated with real-time PCR
• Market Opportunities
  • Ongoing technological integration and development of compact, portable, and lab-on-chip PCR devices
  • Rapid shift from plant-derived to genome-based drug discovery
• Market Challenges
  • Technical limitations of real-time PCR techniques and lack of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Real-time PCR Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Real-time PCR Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Real-time PCR Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Real-time PCR Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Real-time PCR Market

A detailed market share analysis in the Real-time PCR Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Real-time PCR Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Real-time PCR Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Real-time PCR Market

A strategic analysis of the Real-time PCR Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Real-time PCR Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Analytik Jena GmbH, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux Sweden AB, Bioneer Corporation, Danaher Corporation, ELITechGroup, Enzo Life Sciences, Inc., F. Hoffmann-La Roche Ltd., Merck KGaA, Promega Corporation, QIAGEN GmbH, Takara Bio Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Real-time PCR Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Instruments, Reagents & Consumables, and Software & Services.
• Based on Application, market is studied across Clinical, Forensics, and Research.
• Based on End Users, market is studied across Clinical Research Organizations, Forensic Laboratories, Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, and Research Laboratories & Academic Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of infectious diseases and genetic disorders
    • 5.1.1.2. Rapid utilization of biomarker profiling for disease diagnostics
    • 5.1.1.3. Rising early diagnosis of disease-causing microbes and the use of clinical diagnostic tests
  • 5.1.2. Restraints
    • 5.1.2.1. High device costs associated with real-time PCR
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing technological integration and development of compact, portable, and lab-on-chip PCR devices
    • 5.1.3.2. Rapid shift from plant-derived to genome-based drug discovery
  • 5.1.4. Challenges
    • 5.1.4.1. Technical limitations of real-time PCR techniques and lack of skilled professionals
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Real-time PCR Market, by Product

• 6.1. Introduction
• 6.2. Instruments
• 6.3. Reagents & Consumables
• 6.4. Software & Services

7. Real-time PCR Market, by Application

• 7.1. Introduction
• 7.2. Clinical
• 7.3. Forensics
• 7.4. Research

8. Real-time PCR Market, by End Users

• 8.1. Introduction
• 8.2. Clinical Research Organizations
• 8.3. Forensic Laboratories
• 8.4. Hospitals & Diagnostic Centers
• 8.5. Pharmaceutical & Biotechnology Companies
• 8.6. Research Laboratories & Academic Institutes

9. Americas Real-time PCR Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Real-time PCR Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Real-time PCR Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. Analytik Jena GmbH
• 3. Becton, Dickinson and Company
• 4. Bio-Rad Laboratories, Inc.
• 5. bioMerieux Sweden AB
• 6. Bioneer Corporation
• 7. Danaher Corporation
• 8. ELITechGroup
• 9. Enzo Life Sciences, Inc.
• 10. F. Hoffmann-La Roche Ltd.
• 11. Merck KGaA
• 12. Promega Corporation
• 13. QIAGEN GmbH
• 14. Takara Bio Inc.
• 15. Thermo Fisher Scientific Inc.